首页> 美国卫生研究院文献>World Journal of Gastroenterology >Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients
【2h】

Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients

机译:丙型肝炎患者干扰素λ相关基因与治疗反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To determine the association between rapid viral response and IL28B, IL28RA, IL10RB and MxA polymorphisms in the Chinese Han population.METHODS: The study cohort consisted of 238 chronic hepatitis C patients treated with interferon (IFN)-α-2b and ribavirin. Six single nucleotide polymorphisms were genotyped using the ABI TaqMan allelic discrimination assay. Biochemical indices were measured at baseline. Serum hepatitis C virus (HCV) RNA was detected at weeks 0, 4, 12 and 24 of therapy.RESULTS: Only IL28B rs12980275 was associated with treatment response in the Chinese Han population. Patients carrying AG/GG genotypes had a reduced rapid viral response compared with patients carrying the AA genotype (additive model: adjusted OR = 0.43, 95%CI: 0.24-0.75). It took less time for patients with the AA genotype to achieve a viral load < 500 copies/mL (log-rank test, P = 0.004). In addition, the protective effect of genotype AA was independent of baseline viral load. HCV genotype, and baseline white blood cell count, α-fetoprotein and viral load might also help predict treatment response. The area under the receiver-operating characteristic curve was 0.726.CONCLUSION: IL28B rs12980275 AA genotype is a strong predictor of positive response to IFN therapy in Chinese Han patients with hepatitis C.
机译:目的:确定中国汉族人群快速病毒应答与IL28B,IL28RA,IL10RB和MxA多态性之间的关系。方法:该研究队列由238例接受干扰素-α-2b和利巴韦林治疗的慢性丙型肝炎患者组成。使用ABI TaqMan等位基因鉴别分析对6个单核苷酸多态性进行基因分型。在基线测量生化指数。在治疗的第0、4、12和24周时检测到血清丙型肝炎病毒(HCV)RNA。结果:在中国汉族人群中,只有IL28B rs12980275与治疗反应相关。与携带AA基因型的患者相比,携带AG / GG基因型的患者的快速病毒反应降低(累加模型:调整后的OR = 0.43,95%CI:0.24-0.75)。 AA基因型患者花费少于500拷贝/ mL的病毒量花费的时间更少(对数秩检验,P = 0.004)。此外,基因型AA的保护作用与基线病毒载量无关。 HCV基因型,基线白细胞计数,甲胎蛋白和病毒载量也可能有助于预测治疗反应。结论:IL28B rs12980275 AA基因型是中国汉族丙型肝炎患者对IFN治疗阳性反应的有力预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号